Estévez A, Motta A B, Fernández de Gimeno M
Centro de Estudios Farmacológicos y Botánicos (CEFYBO-CONICET) BuenosAires, Argentina.
Medicina (B Aires). 1999;59(5 Pt 1):463-5.
In the corpus luteum (CL) prostaglandin F2 alpha (PGF2 alpha) is a luteolytic agent. Nitric oxide (NO) is a messenger molecule capable of modulating diverse pathophysiological processes. Many of these functions are related with the female reproductive tract. The aim of the present study was to investigate the role of ovarian NO in PGF2 alpha production arid in progesterone synthesis during CL regression in the rat. By means of the intrabursa (i.b.) ovarian sac treatment of two competitive NO inhibitors, NG-monomethyl-L-arginine (L-NMMA; 1 mg/kg); NW-Nitro-L-arginine methyl ester (L-NAME, 3 mg/kg) and sodium nitroprusside (SNP, 0.05 mg/kg) as a NO generator we found that NO, produced by the ovarian tissue during the last days (days 8 and 9) of CL development, acted by increasing PGF2 alpha production in the ovary and diminishing seric progesterone levels leading to CL involution. We also postulated a positive feedback mechanism between PGF2 alpha and NO, to ensure luteal regression. Thus, we injected intraperitoneally (i.p.) a luteolytic dose (3 micrograms/kg) of a synthetic PGF2 alpha during the mid and late phase of CL development. The ovarian activity was evaluated. The results confirmed our hypothesis; we did not see any effect in mid-stage of CL development, while at a late stage enhancement of ovarian NOs activity was observed in PGF2 alpha-infected animals.
在黄体(CL)中,前列腺素F2α(PGF2α)是一种溶黄体因子。一氧化氮(NO)是一种能够调节多种病理生理过程的信使分子。其中许多功能与女性生殖道有关。本研究的目的是探讨卵巢NO在大鼠黄体退化过程中对PGF2α产生及孕酮合成的作用。通过向卵巢囊内注射两种竞争性NO抑制剂,即NG-单甲基-L-精氨酸(L-NMMA;1毫克/千克)、Nω-硝基-L-精氨酸甲酯(L-NAME,3毫克/千克),并注射硝普钠(SNP,0.05毫克/千克)作为NO生成剂,我们发现,在黄体发育的最后几天(第8天和第9天)卵巢组织产生的NO通过增加卵巢中PGF2α的产生以及降低血清孕酮水平,导致黄体退化。我们还推测PGF2α与NO之间存在正反馈机制,以确保黄体退化。因此,在黄体发育的中期和后期,我们腹腔注射(i.p.)溶黄体剂量(3微克/千克)的合成PGF2α,并评估卵巢活性。结果证实了我们的假设;在黄体发育中期未观察到任何影响,而在后期,在注射PGF2α的动物中观察到卵巢NO活性增强。